Desvenlafaxine succinate is an extended-release tablet used to treat major depressive disorder [1]. It is the active metabolite of venlafaxine and works by increasing the levels of serotonin and norepinephrine in the brain [2].
How does desvenlafaxine succinate work?
Desvenlafaxine succinate functions as a serotonin-norepinephrine reuptake inhibitor (SNRI). By blocking the reabsorption of these neurotransmitters in the brain, it helps to improve mood and alleviate symptoms of depression [2].
What is the difference between desvenlafaxine succinate and venlafaxine?
Desvenlafaxine is the primary active metabolite of venlafaxine. This means that after venlafaxine is taken, the body metabolizes it into desvenlafaxine, which then exerts its therapeutic effect. Desvenlafaxine succinate offers a more direct way to achieve these elevated neurotransmitter levels, potentially with a different side effect profile compared to venlafaxine [2].
When does desvenlafaxine succinate's patent expire?
Information on patent expirations for desvenlafaxine succinate can be found on DrugPatentWatch.com. Patents protect the market exclusivity of a drug, and their expiry often opens the door for generic competition [3].
Can generic desvenlafaxine succinate be made?
Once the relevant patents and market exclusivity periods expire, generic versions of desvenlafaxine succinate can be manufactured and marketed [3]. The U.S. Food and Drug Administration (FDA) approves generic drugs to ensure they are safe, effective, and bioequivalent to their brand-name counterparts.
What are the common side effects of desvenlafaxine succinate?
Common side effects associated with desvenlafaxine succinate include nausea, dry mouth, constipation, dizziness, and insomnia [1]. Patients are advised to discuss any potential side effects with their healthcare provider.
How long does it take for desvenlafaxine succinate to work?
Like many antidepressant medications, desvenlafaxine succinate typically requires several weeks of consistent use to show full therapeutic effects [2]. Improvement in mood and reduction in depressive symptoms may be gradual.
Are there any risks or warnings associated with desvenlafaxine succinate?
Desvenlafaxine succinate carries a boxed warning regarding increased suicidal thoughts and behaviors in children, adolescents, and young adults [1]. It should be used with caution in individuals with a history of mania or bipolar disorder, and in those with glaucoma or increased intraocular pressure [2].
Sources:
[1] https://www.druglib.com/patients/desvenlafaxine_succinate/
[2] https://www.ncbi.nlm.nih.gov/books/NBK459207/
[3] https://drugpatentwatch.com/